If you are an accomplished biopharma or medtech executive with interesting views and strong platform skills, we would enjoy getting to know you.
Please note, we are extremely selective about members of our faculty. Most of the meeting circuit has a low bar, thus top executives have fled from attending their conferences.
We offer an executive, curated, and highly-screened community that shares the value of collaboration to accelerate innovation.
Why do we feel this way and how do we know the truth about the industry meeting landscape?
Because ARSENAL is founded and lead by biopharma executives with decades of speaking and publishing in their record.
We have assembled the top questions we get from our biopharma and medtech peers that want to expand their influence and reputation by speaking at our coveted Summits.
Please contact us with any questions you have. Your generous insights can make a difference for others- let’s make that happen.
Attendees are primarily biopharma and medtech executives from the US and EU that are a part of ARSENAL’s opt-in and social media following of over 38,000.
Typically, 300 to 500 people will attend the live sessions and 10x will watch replays within two weeks.
ARSENAL’s team will work with you to showcase your expertise my tailoring the questions and flow of a panel session with fellow peers.
Prior to the event, we use email, document sharing, and a pre-call to align on session objectives, questions, and panelist introductions.
Currently, our events are virtual.
We use a live stream technology called Streamyard to broadcast the summit to our summit site, membership site, and LinkedIn (for some sessions).
Our founder, an accomplished biopharma veteran, spoke at industry conferences while working a big pharma and small biotech. As a result, we do not want speaker to go through a time consuming legal approval process to get slides approved.
All speakers fall under our disclosure that they are speaking independently and their views do not express an agreement or endorsement of their employers.
Around here we say, “share your wisdom, not secrets”.
Over 300 top executives from leading biopharma and medtech companies have been faculty members at our Summits since 2018.
All 25 of the top 25 pharma’s are represented on our faculty.
Faculty members range from CEO’s to Director-level. Departments range from clinical development to commercial to compliance and everywhere in between.
Due to our mission to create safe and productive peer-to-peer ideation, we are not accepting non-industry speakers at this time.
ARSENAL has the largest biopharma/medtech following of any non-media company in the world. Founded by biopharma exec’s, we shape and share best practices in order to help the industry access the ideas that accelerate innovation to serve patients in need.